everlywell

26:I[56264,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"GuestHistoryRecorder"] 27:I[3004,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"EmailPreview"] 2a:I[27201,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js"],"IconMark"] 28:Tb4d4, everlywell

A new way to think about cancer screening

Too many cancers are found too late — often because there's no routine way to screen for them.

But what if you could detect cancer early, sometimes before symptoms appear.

That’s the idea behind multi-cancer early detection.

And it's why we've partnered with Caris Life Science® to bring you Caris Detect.

With a single blood draw, you can screen for signals across 55+ cancers, before symptoms appear.

Because when it comes to cancer, early detection may make all the difference.¹

Learn how Caris Detect works →

Cancer Screening

Biomarker intelligence.
Real-world impact.

Shop

Everlywell 360

Learn

Refer a Friend

Contact

This email was sent by Everlywell

5209 Burnet Road, Suite 300, Austin, TX 78756

Can't see this email? View online.

Privacy Notice Terms of Use Unsubscribe

Caris Detect is a multi-cancer early detection laboratory-developed test performed in a CLIA-certified, CAP-accredited laboratory utilizing whole genome sequencing, whole transcriptome sequencing and advanced artificial intelligence. It is designed to detect early-stage cancer signals from cell-free DNA and cell-free RNA in the blood. Whole exome sequencing and whole transcriptome sequencing (Caris Assure®) are utilized for patients that receive a “Cancer Signal Detected” in order to provide the Suspected Tissue of Origin.

Your purchase may be HSA/FSA eligible. Check with your plan administrator. Everlywell is not responsible for contacting your plan administrator on your behalf.

Everlywell works with a network of licensed clinicians who review your request and order the test. Caris Detect™ Multi-Cancer Early Detection Test is performed by Caris Life Sciences' CLIA-certified, CAP-accredited laboratory. Results are provided to you and made available in your online portal.

Caris Detect does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results may occur. Caris Detect is intended to complement, not replace, recommended cancer screening tests and other medical evaluations, so it is important that you continue recommended cancer screenings and routine preventive healthcare based on your individual risk factors.

Results should be interpreted in conjunction with discussion with your healthcare provider and potential follow-up diagnostic testing. A positive result is not a diagnosis. A negative result does not rule out cancer or mean that an individual will not develop cancer in the future.

¹ https://pressroom.cancer.org/cancer-statistics-report-2026
American Cancer Society, Cancer Facts & Figures 2025 and Cancer Statistics, 2026. Five-year relative survival rates vary by stage at diagnosis and cancer type; earlier-stage diagnoses are generally associated with higher survival rates than distant-stage (metastatic) diagnoses.

29:T1182,everlywell Introducing Caris Detect Multi-Cancer Early Detection Test. A new way to think about cancer screening Too many cancers are found too late — often because there's no routine way to screen for them. But what if you could detect cancer early, sometimes before symptoms appear. That’s the idea behind multi-cancer early detection. And it's why we've partnered with Caris Life Science® to bring you Caris Detect. With a single blood draw, you can screen for signals across 55+ cancers, before symptoms appear. Because when it comes to cancer, early detection may make all the difference.1 Learn how Caris Detect works → Cancer Screening Biomarker intelligence. Real-world impact. Shop Everlywell 360 Learn Refer a Friend Contact This email was sent by Everlywell 5209 Burnet Road, Suite 300, Austin, TX 78756 Can't see this email? View online . Privacy Notice Terms of Use Unsubscribe Caris Detect is a multi-cancer early detection laboratory-developed test performed in a CLIA-certified, CAP-accredited laboratory utilizing whole genome sequencing, whole transcriptome sequencing and advanced artificial intelligence. It is designed to detect early-stage cancer signals from cell-free DNA and cell-free RNA in the blood. Whole exome sequencing and whole transcriptome sequencing (Caris Assure®) are utilized for patients that receive a “Cancer Signal Detected” in order to provide the Suspected Tissue of Origin. Your purchase may be HSA/FSA eligible. Check with your plan administrator. Everlywell is not responsible for contacting your plan administrator on your behalf. Everlywell works with a network of licensed clinicians who review your request and order the test. Caris Detect™ Multi-Cancer Early Detection Test is performed by Caris Life Sciences' CLIA-certified, CAP-accredited laboratory. Results are provided to you and made available in your online portal. Caris Detect does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results may occur. Caris Detect is intended to complement, not replace, recommended cancer screening tests and other medical evaluations, so it is important that you continue recommended cancer screenings and routine preventive healthcare based on your individual risk factors. Results should be interpreted in conjunction with discussion with your healthcare provider and potential follow-up diagnostic testing. A positive result is not a diagnosis. A negative result does not rule out cancer or mean that an individual will not develop cancer in the future. 1 https://pressroom.cancer.org/cancer-statistics-report-2026 American Cancer Society, Cancer Facts & Figures 2025 and Cancer Statistics, 2026. Five-year relative survival rates vary by stage at diagnosis and cancer type; earlier-stage diagnoses are generally associated with higher survival rates than distant-stage (metastatic) diagnoses. 1f:["$","article",null,{"className":"min-w-0 flex-1 overflow-hidden","aria-label":"Early detection may be your best advantage","children":[["$","$L26",null,{"emailId":"937780ce-6186-4f64-8e80-b2e49cd7bd98"}],["$","$L27",null,{"email":{"id":"937780ce-6186-4f64-8e80-b2e49cd7bd98","subject":"Early detection may be your best advantage","previewText":"everlywell Introducing Caris Detect Multi-Cancer Early Detection Test. \n\n \n\n\n\n\nA new way to think about cancer screening\n\n\n \n\n\n\n Too many cancers are found too late — often becau","sentAt":"2026-09-16T13:46:32.000Z","classification":"marketing","imageCount":11,"thumbnailUrl":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b8eb296229ef3f9dfb4336162c3ccd837bf9b9ce52816badbd324a16f5577118","emailType":"product_launch","typeConfidence":"guess","typeBasis":"matched the body copy","brand":"$24:props:brands:312","bodyHtml":"$28","textBody":"$29","bodyFallback":null}}]]}] a:null f:[["$","title","0",{"children":"Early detection may be your best advantage by EverlyWell | Mailspo"}],["$","meta","1",{"name":"description","content":"everlywell Introducing Caris Detect Multi-Cancer Early Detection Test. \n\n \n\n\n\n\nA new way to think a"}],["$","meta","2",{"name":"robots","content":"index, follow"}],["$","link","3",{"rel":"canonical","href":"https://mailspo.com/emails/937780ce-6186-4f64-8e80-b2e49cd7bd98"}],["$","meta","4",{"property":"og:title","content":"Early detection may be your best advantage by EverlyWell | Mailspo"}],["$","meta","5",{"property":"og:description","content":"everlywell Introducing Caris Detect Multi-Cancer Early Detection Test. \n\n \n\n\n\n\nA new way to think a"}],["$","meta","6",{"property":"og:url","content":"https://mailspo.com/emails/937780ce-6186-4f64-8e80-b2e49cd7bd98"}],["$","meta","7",{"property":"og:site_name","content":"Mailspo"}],["$","meta","8",{"property":"og:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b8eb296229ef3f9dfb4336162c3ccd837bf9b9ce52816badbd324a16f5577118"}],["$","meta","9",{"property":"og:image:alt","content":"EverlyWell email creative: Early detection may be your best advantage"}],["$","meta","10",{"property":"og:type","content":"article"}],["$","meta","11",{"property":"article:published_time","content":"2026-09-16T13:46:32.000Z"}],["$","meta","12",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","13",{"name":"twitter:title","content":"Early detection may be your best advantage by EverlyWell | Mailspo"}],["$","meta","14",{"name":"twitter:description","content":"everlywell Introducing Caris Detect Multi-Cancer Early Detection Test. \n\n \n\n\n\n\nA new way to think a"}],["$","meta","15",{"name":"twitter:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b8eb296229ef3f9dfb4336162c3ccd837bf9b9ce52816badbd324a16f5577118"}],["$","meta","16",{"name":"twitter:image:alt","content":"EverlyWell email creative: Early detection may be your best advantage"}],["$","link","17",{"rel":"icon","href":"/favicon.ico?favicon.3lxqohtg4uvbd.ico","sizes":"48x48","type":"image/x-icon"}],["$","$L2a","18",{}]]

Search Mailspo